NeuroSense Therapeutics Ltd. financial data

Symbol
NRSN, NRSNW on Nasdaq
Location
11 Hamenofim St., Building B, Herzliya, Israel
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Apr 7, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.2M shares +51%
Common Stock, Shares, Outstanding 24.6M shares +36.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 666K USD -44.9%
Assets, Current 1.56M USD -3.89%
Property, Plant and Equipment, Net 63K USD -18.2%
Operating Lease, Right-of-Use Asset 42K USD -65.9%
Assets 1.68M USD -8.53%
Employee-related Liabilities, Current 498K USD -66.4%
Liabilities, Current 2.2M USD -37.2%
Operating Lease, Liability, Noncurrent 36K USD
Liabilities 2.2M USD -37.8%
Retained Earnings (Accumulated Deficit) -41.4M USD -27.8%
Stockholders' Equity Attributable to Parent -519K USD +69.5%
Liabilities and Equity 1.68M USD -8.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 90M shares +50%
Common Stock, Shares, Issued 24.6M shares +36.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 666K USD -44.9%
Deferred Tax Assets, Valuation Allowance 7.13M USD +47.7%
Deferred Tax Assets, Gross 7.15M USD +47%
Operating Lease, Liability 73K USD +5.8%
Lessee, Operating Lease, Liability, to be Paid 75K USD -50.7%
Property, Plant and Equipment, Gross 126K USD +2.44%
Operating Lease, Liability, Current 73K USD +5.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 78K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 75K USD +1.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -80%
Deferred Tax Assets, Operating Loss Carryforwards 5.69M USD +71.6%
Deferred Tax Assets, Net of Valuation Allowance 7.13M USD +47.7%